Is UNII-LIJ4CT1Z3Y Safe in Breastfeeding
Question
I am a breastfeeding mother and i want to know if it is safe to use UNII-LIJ4CT1Z3Y? Is UNII-LIJ4CT1Z3Y safe for nursing mother and child? Does UNII-LIJ4CT1Z3Y extracts into breast milk? Does UNII-LIJ4CT1Z3Y has any long term or short term side effects on infants? Can UNII-LIJ4CT1Z3Y influence milk supply or can UNII-LIJ4CT1Z3Y decrease milk supply in lactating mothers?
Answer by DrLact: About UNII-LIJ4CT1Z3Y usage in lactation
No information is available on the clinical use of UNII-LIJ4CT1Z3Y during breastfeeding. Because UNII-LIJ4CT1Z3Y is more than 99% bound to plasma proteins, the amount in milk is likely to be low. However, its half-life is about 33 hours and it might accumulate in the infant. The manufacturer recommends that breastfeeding be discontinued during UNII-LIJ4CT1Z3Y therapy and for 1 week after the last dose.
Alternate Drugs
Tamoxifen(Dangerous)
Erlotinib(Unsafe)
Letrozole(Dangerous)
Mitoxantrone(Dangerous)
Trastuzumab(Unsafe)
Exemestane(Dangerous)
Mercaptopurine(Safe)
Cladribine(Dangerous)
Nivolumab(Unsafe)
Hydroxyurea(Low Risk)
Vinblastine(Dangerous)
Ipilimumab(Unsafe)
Etoposide(Dangerous)
Bleomycin(Dangerous)
Cetuximab(Unsafe)
Vinorelbine(Dangerous)
Imatinib(Unsafe)
Carboplatin(Dangerous)
Doxorubicin(Dangerous)
Dacarbazine(Dangerous)
Paclitaxel(Dangerous)
Cyclophosphamide(Dangerous)
Azelaic Acid(Safe)
Dasatinib(Unsafe)
Fluorouracil(Dangerous)
Cisplatin(Unsafe)
Docetaxel(Dangerous)
Alemtuzumab(Low Risk)
Dactinomycin(Dangerous)
Busulfan(Dangerous)
Rituximab(Low Risk)
Gemcitabine(Dangerous)
Bevacizumab(Low Risk)
Thioguanine(Dangerous)
Nilotinib(Unsafe)
Pazopanib(Unsafe)
Vincristine(Dangerous)
Imatinib(Unsafe)
Dasatinib(Unsafe)
Gemcitabine(Dangerous)
Orlistat(Low Risk)
Nilotinib(Unsafe)
Pazopanib(Unsafe)
Allopurinol(Safe)
Erlotinib(Unsafe)
Imatinib(Unsafe)
Dasatinib(Unsafe)
Nilotinib(Unsafe)
Pazopanib(Unsafe)
Erlotinib(Unsafe)
Imatinib(Unsafe)
Dasatinib(Unsafe)
Nilotinib(Unsafe)
Pazopanib(Unsafe)
Erlotinib(Unsafe)
Imatinib(Unsafe)
Dasatinib(Unsafe)
Nilotinib(Unsafe)
Pazopanib(Unsafe)
Erlotinib(Unsafe)